Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

There are now a number of other drugs in the same class in different stages of development, which have been shown to be even more potent inhibitors of hepatitis B replication. The large experience ...

By targeting these pathways, we can develop therapies that not only suppress viral replication but also offer a functional cure for chronic hepatitis B," he said. The implications of this review are ...

Hepatitis B is a lifelong infection of the liver caused ... traditional therapeutics for most patients - can inhibit viral replication and bring hepatitis under control, but they cannot eradicate ...

Despite numerous treatment advances, chronic hepatitis B virus (HBV) infection remains ... an immune system response and suppressing viral replication to protect healthy hepatocytes may result ...